Measurable residual disease in multiple myeloma: ready for clinical practice?

  1. Burgos, L.
  2. Puig, N.
  3. Cedena, M.-T.
  4. Mateos, M.-V.
  5. Lahuerta, J.J.
  6. Paiva, B.
  7. San-Miguel, J.F.
Revue:
Journal of hematology & oncology

ISSN: 1756-8722

Année de publication: 2020

Volumen: 13

Número: 1

Pages: 82

Type: Révision

DOI: 10.1186/S13045-020-00911-4 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus